Company profile · Sponsor
Jasper
Jasper Therapeutics
- Pipeline
- 13
- Drugs
- 0
- Patents
- 1
Quick answer
Jasper (JSPR) is a biotech company. headquartered in REDWOOD CITY, CA, USA. listed on NYSE. NovaPharmaNews links 13 pipeline programs, 0 drugs, and 1 patent to this profile..
Company facts
Pipeline (13)
Search pipeline →-
Nicotine patch
Jasper
Nicotine Dependence
1 trial -
Briquilimab
Jasper
Chronic Spontaneous Urticaria
1 trial -
Briquilimab
Jasper
Chronic Urticaria
1 trial -
Briquilimab
Jasper
Chronic Inducible Urticaria
1 trial -
Briquilimab
Jasper
Urticaria Chronic
1 trial -
EPINEPHRINE , Briquilimab
Jasper
Chronic Inducible Urticaria
1 trial -
Humanized anti-CD117 Monoclonal Antibody (JSP191)
Jasper
SCID
1 trial -
Placebo (10 mM sodium acetate, 9.0% (w/v) sucrose, 0.02% (w/v) polysorbate 20, pH 5.2), EPINEPHRINE , Briquilimab
Jasper
Chronic Spontaneous Urticaria
1 trial -
A double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of briquilimab in participants with allergic asthma.
Jasper
allergic asthma
1 trial -
Briquilimab
Jasper
Allergic Asthma
1 trial -
Humanized anti-CD117 Monoclonal Antibody (JSP191)
Jasper
MYELODYSPLASTIC SYNDROME; MDS
1 trial -
JSP191
Jasper
Lower-risk Myelodysplastic Syndrome
1 trial -
Nelfinavir and Omeprazole
Jasper
Healthy Volunteers
1 trial
Patents (1)
Search patents →Frequently asked questions
What is Jasper?
Jasper (JSPR) is a biotech company. headquartered in REDWOOD CITY, CA, USA. listed on NYSE. NovaPharmaNews links 13 pipeline programs, 0 drugs, and 1 patent to this profile..
What pipeline programs does Jasper sponsor?
We track 13 ClinicalTrials.gov-linked programs for Jasper, including Nicotine patch and 12 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does Jasper company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.